Syneron Medical (Syneron Medical) Interest Coverage : 0 (At Loss) (As of Mar. 2017)

View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Syneron Medical's Operating Income for the three months ended in Mar. 2017 was $-3.9 Mil. Syneron Medical's Interest Expense for the three months ended in Mar. 2017 was $-0.7 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Syneron Medical's Interest Coverage or its related term are showing as below:

ELOS's Interest Coverage is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 18.745
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneron Medical Interest Coverage Historical Data

The historical data trend for Syneron Medical's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Syneron Medical Interest Coverage Chart

Syneron Medical Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Interest Coverage

Get a 7-Day Free Trial

No Debt

14.74

Syneron Medical Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Interest Coverage	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	1.23	-

Competitive Comparison of Syneron Medical's Interest Coverage

For the Medical Devices subindustry, Syneron Medical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneron Medical's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Syneron Medical's Interest Coverage falls into.

Syneron Medical Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneron Medical's Interest Coverage for the fiscal year that ended in Dec. 2016 is calculated as

Here, for the fiscal year that ended in Dec. 2016, Syneron Medical's Interest Expense was $-0.2 Mil. Its Operating Income was $3.2 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.0 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2016 )	/	Interest Expense (A: Dec. 2016 )
	=	-1	*	3.228	/	-0.219
	=	14.74

Syneron Medical's Interest Coverage for the quarter that ended in Mar. 2017 is calculated as

Here, for the three months ended in Mar. 2017, Syneron Medical's Interest Expense was $-0.7 Mil. Its Operating Income was $-3.9 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.0 Mil.

Syneron Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's Financial Strength is.

Syneron Medical (NAS:ELOS) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Syneron Medical Interest Coverage Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneron Medical (Syneron Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.syneron.com

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.

Executives

North Tide Capital, Llc	10 percent owner	500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan	director, 10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp	10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines

From GuruFocus

Seth Klarman Buys First American Corp., Universal Compression Holdings, School Specialty Inc., Sells Courtside Acquisition Corp, Healthsouth Corp.

By gurufocus • 08-13-2007

Top Seth Klarman Holding, ELOS Rockets Up 20%

By matsandalex matsandalex • 02-17-2011

Seth Klarman More Than Doubles Holdings in Syneron Medical

By teddycx teddycx • 07-12-2011

Why Is Seth Klarman Loading Up on Syneron Medical?

By matsandalex matsandalex • 08-29-2011